TECH NEWS
Backed By Alphabet, Isomorphic Labs Raises $2.1 Billion To Scale AI Drug Discovery Platform
Isomorphic Labs, the AI-first drug discovery company founded by Demis Hassabis, has raised $2.1 billion in a Series B funding round as competition intensifies around artificial intelligence-driven healthcare and pharmaceutical research. The funding round was led by Thrive Capital and included participation from existing investors Alphabet and GV (formerly